Gustavo De La Cruz ReynozoAssociateK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmail617-951-9041 Professional Biography Gustavo De La Cruz Reynozo is an associate in the firm’s Boston office. He is a member of the Asset Management and Investment Funds practice group. More Legal and Business Bylines From Gustavo De La Cruz Reynozo Checked Swing—SEC Does Not Adopt "Swing Pricing" or a "Hard Close" for Now, but Only Provides Liquidity Guidance and Amendments to Forms N-Port and N-Cen - (Posted On Wednesday, September 11, 2024) United States: CFTC Proposes to Broaden Scope of Eligible Collateral for Initial Margin - (Posted On Friday, July 28, 2023) The SEC Significantly Expands the Scope of Form PF Reporting - (Posted On Saturday, May 13, 2023) United States: SEC Adopts Amendments to Form PF and Significantly Expands Reporting Requirements - (Posted On Thursday, May 04, 2023) United States: SEC Proposes Amendments to Broaden the Scope of Regulation S-P in Response to Digital Communications and Risks to Customer Personal Information - (Posted On Friday, March 17, 2023) Current Legal Analysis The Brobdingnagian Immodesty Of The CTA by: Keith Paul Bishop US Supreme Court Holds that Federal Courts Do Not Have Jurisdiction to Review Petition Revocations by USCIS by: Cynthia Scribe China’s National People’s Congress Releases Draft of the Anti-Unfair Competition Law for Comment by: Aaron Wininger New California Law Aimed at Deceptive Ad Claims Regarding Digital Products by: Richard B. Newman Updates to the Corporate Transparency Act's Beneficial Ownership Information Reporting Requirements by: Bryce Ellis , Keith Paul Bishop Corporate Transparency Act Enforcement Resumes with Extended Deadlines by: Kathleen M. Porter , Kiernan L. Ignacio CTA Injunction Stayed; FinCEN Extends Reporting Deadlines by: Corporate Compliance, Investigations and Defense Andrews Kurth CTA Revived: Corporate Transparency Act Injunction Lifted by Federal Court and Filing Deadlines Extended by: David E. Weiss , Virginia B. Wilson Upcoming Events Jan 8 2025 Key Proposals in the CY2026 Medicare Advantage and Part D Proposed Rule Jan 8 2025 Whistleblower Protections: Navigating Health Care Employment & Labor Rights Jan 14 2025 What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025 Jan 15 2025 Healthy AI Roundtable Chicago Jan 31 2025 Mass Actions: Bankruptcies, MDLs, Class Actions & Harrington v. Purdue Feb 26 2025 MCLE Triple Play Print
